Latest News
From the Journals
Targeted HCV patients improve on sofosbuvir/daclatasvir combination
A combination of sofosbuvir/daclatasvir yielded sustained virological responses at 12 weeks after the last treatment in 95% of hepatitis C virus–...
From the Journals
Healthy donor stool safe, effective for recurrent CDI
For patients with recurrent Clostridium difficile infection (CDI), donor stool administered via colonoscopy achieved clinical cure significantly...